Clinical Trials Directory

Trials / Completed

CompletedNCT03116763

The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis

The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
164 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).

Detailed description

Arthritis is a common childhood illness that makes everyday activities hard for young people. It is a long-lasting illness that can make you feel pain, tired and emotionally upset. This can make it hard for children and teens to see friends and do the activities that they like. The goal of this project is to find out if the newly developed peer mentoring program called iPeer2Peer helps teens with arthritis take better care of their illness and feel more connected to other people with arthritis. The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).

Conditions

Interventions

TypeNameDescription
BEHAVIORALiPeer2Peer Mentorship10 sessions of 20-30 minute Skype calls conducted over 5-12 weeks.
OTHERActive Comparator: Control GroupThe control group will receive standard care but without the iPeer2Peer program.

Timeline

Start date
2017-03-28
Primary completion
2023-04-16
Completion
2023-04-16
First posted
2017-04-17
Last updated
2023-11-24

Locations

6 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT03116763. Inclusion in this directory is not an endorsement.